There is a "high degree of uncertainty" over how much of the hundreds of millions of pounds lent to sports bodies during the ...
MILAN (Reuters) -Italian drugmaker Angelini Pharma is keen on M&A, even after its offer to buy bigger rival Recordati fell through despite having the support of potential financial partners, its Chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results